{
    "clinical_study": {
        "@rank": "33275", 
        "arm_group": [
            {
                "arm_group_label": "Antioxidant supplementation", 
                "arm_group_type": "Active Comparator", 
                "description": "Randomized to receive antioxidant supplementation (vitamin C, 500 mg; beta carotene, 15 mg; and alpha-tocopherol, 400 IU) three times per week for five years."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Randomized to receive placebo three times per week for five years"
            }
        ], 
        "brief_summary": {
            "textblock": "Aravind Eye Hospital and the University of California, San Francisco (UCSF) Proctor\n      Foundation collaborated on the Antioxidants for the Prevention of Cataract Study from\n      1997-2002. (1) In the study, 798 participants aged 35-50 years were enrolled from 5 rural\n      villages, and randomized to thrice weekly antioxidants (vitamin C, 500 mg; beta carotene, 15\n      mg; and alpha-tocopherol, 400 IU) or placebo. After 5 years of supplementation, there was no\n      significant difference in cataract formation between the antioxidant group and placebo. In\n      this follow-up study, we will return to study villages to determine whether rates of\n      cataract surgery are different in the 2 groups.\n\n      1. Gritz DC, Srinivasan M, Smith SD, et al. The Antioxidants in Prevention of Cataracts\n      Study: effects of antioxidant supplements on cataract progression in South India. The\n      British journal of ophthalmology 2006;90:847-51."
        }, 
        "brief_title": "Antioxidants for Prevention of Cataracts Follow-up Study", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cataract", 
        "condition_browse": {
            "mesh_term": "Cataract"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  participation in previous cataract study\n\n        Exclusion Criteria:\n\n          -  refusal to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "798", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01664819", 
            "org_study_id": "P0047247"
        }, 
        "intervention": {
            "arm_group_label": "Antioxidant supplementation", 
            "intervention_name": "Antioxidant", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": "Antioxidants"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Madurai", 
                    "country": "India", 
                    "state": "Tamil Nadu"
                }, 
                "name": "Aravind Eye Hospitals"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Antioxidants for Prevention of Cataracts Follow-up Study", 
        "overall_official": [
            {
                "affiliation": "University of California, San Francisco", 
                "last_name": "Jeremy D Keenan, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Aravind Eye Hospitals", 
                "last_name": "Muthiah Srinivasan, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Effect of intervention on cataract surgery 15 years post-intervention in a logistic regression model", 
            "measure": "Cataract surgery", 
            "safety_issue": "No", 
            "time_frame": "15 years post-intervention"
        }, 
        "reference": {
            "PMID": "16556618", 
            "citation": "Gritz DC, Srinivasan M, Smith SD, Kim U, Lietman TM, Wilkins JH, Priyadharshini B, John RK, Aravind S, Prajna NV, Duraisami Thulasiraj R, Whitcher JP. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006 Jul;90(7):847-51. Epub 2006 Mar 23."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01664819"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Association of risk factors assessed via questionnaire 15 years ago with cataract surgery in a multiple logistic regression model", 
                "measure": "Risk factors for cataract surgery", 
                "safety_issue": "No", 
                "time_frame": "15 years post-intervention"
            }, 
            {
                "measure": "All-cause mortality", 
                "safety_issue": "No", 
                "time_frame": "15 years post-intervention"
            }
        ], 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "collaborator": {
                "agency": "Aravind Eye Hospitals, India", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}